Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Michele Magnesa"'
Autor:
Pietro Scicchitano, Massimo Iacoviello, Francesco Massari, Micaela De Palo, Pasquale Caldarola, Antonia Mannarini, Andrea Passantino, Marco Matteo Ciccone, Michele Magnesa
Publikováno v:
Biomedicines, Vol 10, Iss 7, p 1721 (2022)
Heart failure (HF) is a worrisome cardiac pandemic with a negative prognostic impact on the overall survival of individuals. International guidelines recommend up-titration of standardized therapies in order to reduce symptoms, hospitalization rates,
Externí odkaz:
https://doaj.org/article/4f5179430e754025b5263965ae98405a
Autor:
Michele Correale, Martino Fortunato, Michele Magnesa, Giuseppe Varricchione, Giulio Campanale, Matteo Gravina, Matteo Di Biase, Natale Daniele Brunetti
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
We report the case of 63-year-old man, complaining of dyspnea and with abnormal systolic motion of the interventricular septum at echocardiography, referred for coronary angiography and suspect coronary artery disease. In the presence of normal coron
Externí odkaz:
https://doaj.org/article/14da9c45cd5243ff8c2e5201b7f97a61
Autor:
Lucia Tricarico, Massimo Iacoviello, Alessandra Leopizzi, Giuseppe Pastore, Matteo Di Biase, Michele Magnesa, Olga Lamacchia, Salvatore Tucci, Adriana Mallardi, Pietro Mazzeo, Martino Fortunato, Pasquale Maiellaro, Michele Correale, Natale Daniele Brunetti
Publikováno v:
Cardiovascular Drugs and Therapy. 36:1157-1164
Purpose The use of sodium-glucose-cotransporter-type-2 inhibitors (SGLT2i) was associated in previous studies with an improved vascular function in non-human experimental models. We therefore sought to evaluate possible changes in endothelial functio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c8618d34ad9a2c2cc00a603717890f6
https://doi.org/10.1007/s10557-021-07254-3
https://doi.org/10.1007/s10557-021-07254-3
Autor:
Enrica Vitale, Matteo Di Biase, Massimo Iacoviello, Lucia Tricarico, Grazia Casavecchia, Riccardo Ieva, Michele Magnesa, Marco Mele, Natale Daniele Brunetti, Maria Delia Corbo
Publikováno v:
The American Journal of Emergency Medicine. 47:145-148
Background Percutaneous coronary intervention (PCI) represents the best therapeutic option for type-1 myocardial infarction (T1MI) in the majority of clinical settings; its role in the treatment of type-2 myocardial infarction (T2MI), however, remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e4cdd7bf760ae8f63633926d2d29b37
https://doi.org/10.1016/j.ajem.2021.03.042
https://doi.org/10.1016/j.ajem.2021.03.042
Autor:
Michele Correale, Pietro Mazzeo, Lucia Tricarico, Francesca Croella, Martino Fortunato, Michele Magnesa, Marco Amatruda, Simona Alfieri, Salvatore Ferrara, Vincenzo Ceci, Giuseppe Dattilo, Marco Mele, Massimo Iacoviello, Natale Daniele Brunetti
Publikováno v:
Clinical drug investigation. 42(7)
Cardiac remodelling is an adverse phenomenon linked to heart failure progression and an important contributor to heart failure severity. Cardiac remodelling could represent the real therapeutic goal in the treatment of patients with heart failure wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f8f24506fde00f7dc9267f0778f86da
https://pubmed.ncbi.nlm.nih.gov/35726047
https://pubmed.ncbi.nlm.nih.gov/35726047
Autor:
Michele Magnesa, Grazia Casavecchia, Roberta Barone, Mariolina Riccardo, Delia Corbo, Natale Daniele Brunetti
Publikováno v:
European Heart Journal Supplements. 23
Case report A 56-year-old man affected by micromolecular multiple myeloma was treated by several cycles of different chemotherapy drugs from September 2015 to December 2020. The chemotherapy regimen included 4-cycle first-line therapy with Bortezomib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::822d01e04ddb6aefc773a97e47c5f90f
https://doi.org/10.1093/eurheartj/suab130.001
https://doi.org/10.1093/eurheartj/suab130.001
Autor:
Lucia Tricarico, Paola Persichella, Pietro Mazzeo, Alessandra Leopizzi, Adriana Mallardi, Michele Magnesa, Martino Fortunato, Francesca Croella, Simona Alfieri, Michele Correale, Massimo Iacoviello, Natale D Brunetti
Publikováno v:
European Heart Journal Supplements. 23
Aim Acute coronary syndromes (ACS) represent one of the major causes of mortality in our country. Lung ultrasound is an important diagnostic tool in the assessment of lung and pleural diseases; it is easy to perform and provides low-cost analysis and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a996d83e84edfa159e395c72d115945
https://doi.org/10.1093/eurheartj/suab126.001
https://doi.org/10.1093/eurheartj/suab126.001
Autor:
Michele Magnesa, Pietro Mazzeo, Martino Fortunato, Raffaele Mennella, Lucia Tricarico, Michele Correale, Francesca Croella, Adriana Mallardi, Alessandra Leopizzi, Vincenzo Ceci, Simona Alfieri, Massimo Iacoviello, Matteo Di Biase, Natale Daniele Brunetti
Publikováno v:
European Heart Journal Supplements. 23
Aims Left atrial (LA) enlargement has been demonstrated to be a predictor of adverse cardiovascular outcomes, such as atrial fibrillation (AF), heart failure (HF), and cardiovascular death. Previous studies showed left ventricle ejection fraction (LV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fce081f7fdcd25d3a1caf2bbe22acf2
https://doi.org/10.1093/eurheartj/suab139.005
https://doi.org/10.1093/eurheartj/suab139.005
Autor:
Maria Concetta Pastore, Giulia Elena Mandoli, Alberto Giannoni, Giovanni Benfari, Frank Lloyd Dini, Gianmarco Rosa, Nicola Riccardo Pugliese, Claudia Taddei, Michele Correale, Natale Daniele Brunetti, Michele Magnesa, Erberto Carluccio, Anna Mengoni, Andrea Igoren Guaricci, Laura Piscitelli, Rodolfo Citro, Michele Ciccarelli, Giuseppina Novo, Egle Corrado, Annalisa Pasquini, Valentina Loria, Giuseppe De Carli, Anna Degiovanni, Giuseppe Patti, Ciro Santoro, Luca Moderato, Mariantonietta Cicoira, Marco Canepa, Alessandro Malagoli, Michele Emdin, Matteo Cameli
Publikováno v:
European Heart Journal Supplements. 23
Aims This sub-study deriving from a multicentre Italian register (DISCOVER-ARNI) investigated whether sacubitril/valsartan in adjunction of optimal medical therapy (OMT) could reduce the rate of implantable cardioverter-defibrillator(ICD) indications
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7242719e05c6b8577f09cd3a9a5ee0c
https://doi.org/10.1093/eurheartj/suab139.039
https://doi.org/10.1093/eurheartj/suab139.039
Autor:
Michele Correale, Michele Magnesa, Pietro Mazzeo, Martino Fortunato, Lucia Tricarico, Alessandra Leopizzi, Adriana Mallardi, Raffaele Mennella, Francesca Croella, Massimo Iacoviello, Matteo Di Biase, Natale Daniele Brunetti
Publikováno v:
Journal of Clinical Medicine
Volume 12
Issue 3
Pages: 1086
Volume 12
Issue 3
Pages: 1086
(1) Background: Previous studies showed left ventricular (LV) and left atrial (LA) improvement and reverse remodeling after therapy with Sacubitril/Valsartan (S/V) in patients affected by heart failure with reduced ejection fraction (HFrEF). Therefor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e54830511682cfd31bb920eb9edbcda
https://doi.org/10.3390/jcm12031086
https://doi.org/10.3390/jcm12031086